These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33216051)

  • 1. Shifting to a Biomarker Paradigm Across Cancer Care.
    Mahon SM
    Clin J Oncol Nurs; 2020 Dec; 24(6):633-634. PubMed ID: 33216051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New directions in biomarker research, drug development and personalized medicine].
    Németh G; Jelinek I
    Magy Onkol; 2013 Mar; 57(1):5-10. PubMed ID: 23573515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of risk models and molecular diagnostics to permit personalized management of cancer.
    Pu X; Ye Y; Wu X
    Cancer; 2014 Jan; 120(1):11-9. PubMed ID: 24114238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.
    Saumet A; Lecellier CH
    Adv Exp Med Biol; 2015; 888():5-15. PubMed ID: 26663176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlocking the potential of oncology biomarkers: advancements in clinical theranostics.
    Dubey AK; Kaur I; Madaan R; Raheja S; Bala R; Garg M; Kumar S; Lather V; Mittal V; Pandita D; Gundamaraju R; Singla RK; Sharma R
    Drug Metab Pers Ther; 2024 Mar; 39(1):5-20. PubMed ID: 38469723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.
    Kamel HFM; Al-Amodi HSAB
    Genomics Proteomics Bioinformatics; 2017 Aug; 15(4):220-235. PubMed ID: 28813639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward Personalized Cancer Treatment: From Diagnostics to Therapy Monitoring in Miniaturized Electrohydrodynamic Systems.
    Khondakar KR; Dey S; Wuethrich A; Sina AA; Trau M
    Acc Chem Res; 2019 Aug; 52(8):2113-2123. PubMed ID: 31293158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Medicine: Accelerating the Science to Revolutionize Cancer Care
.
    Brant JM; Mayer DK
    Clin J Oncol Nurs; 2017 Dec; 21(6):722-729. PubMed ID: 29149123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics: current applications and future prospects towards personalized therapeutics.
    Vaiopoulou A; Gazouli M; Karikas GA
    J BUON; 2013; 18(3):570-8. PubMed ID: 24065466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized Assessment for Cancer Prevention, Detection, and Treatment.
    Paleari L
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioanalysis for precision medicine.
    Yang S; Yang Z; Wang PG
    Bioanalysis; 2019 Jun; 11(11):1039-1043. PubMed ID: 31251103
    [No Abstract]   [Full Text] [Related]  

  • 12. Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial.
    Le Tourneau C; Kamal M; Trédan O; Delord JP; Campone M; Goncalves A; Isambert N; Conroy T; Gentien D; Vincent-Salomon A; Pouliquen AL; Servant N; Stern MH; Le Corroller AG; Armanet S; Rio Frio T; Paoletti X
    Target Oncol; 2012 Dec; 7(4):253-65. PubMed ID: 23161020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative methods for biomarker discovery in the evaluation and development of cancer precision therapies.
    Umelo IA; Costanza B; Castronovo V
    Cancer Metastasis Rev; 2018 Mar; 37(1):125-145. PubMed ID: 29392535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Biomarker Discovery for Precision Medicine: New Progress.
    Zou J; Wang E
    Curr Med Chem; 2019; 26(42):7655-7671. PubMed ID: 30027846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine.
    Bashraheel SS; Domling A; Goda SK
    Biomed Pharmacother; 2020 May; 125():110009. PubMed ID: 32106381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic lethality: a step forward for personalized medicine in cancer.
    Jariyal H; Weinberg F; Achreja A; Nagarath D; Srivastava A
    Drug Discov Today; 2020 Feb; 25(2):305-320. PubMed ID: 31811941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.
    Donovan MJ; Cordon-Cardo C
    Mol Diagn Ther; 2017 Apr; 21(2):115-123. PubMed ID: 28000172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics in the age of personalized medicine.
    Dickmann LJ; Ware JA
    Drug Discov Today Technol; 2016; 21-22():11-16. PubMed ID: 27978982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer molecular markers: A guide to cancer detection and management.
    Nair M; Sandhu SS; Sharma AK
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):39-55. PubMed ID: 29428478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biology in medical oncology: diagnosis, prognosis, and precision medicine.
    Aftimos PG; Barthelemy P; Awada A
    Discov Med; 2014 Feb; 17(92):81-91. PubMed ID: 24534471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.